Shelby Reed, PhD, RPh is Professor in Population Health Sciences and Medicine at Duke University and Director of the Center for Informing Health Decisions at the Duke Clinical Research Institute. Dr. Reed has 20 years of experience leading multidisciplinary studies in health economics and outcomes research. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of diagnostics, drugs and patient-centered interventions. In her work on health policy issues, she developed computer models to evaluate the economic impact of trends in clinical trial design, changes in reimbursement policies, new financing schemes to spur drug development for ultra-rare conditions, and the societal value of alternative approaches to identifying drug safety problems. She also co-founded the Preference Evaluation Research (PrefER) Group that focuses on applying stated-preference methods to evaluate benefit-risk tradeoffs, patient-centered value, and their application in comparative effectiveness research and clinical decision making. Dr. Reed earned pharmacy and doctoral degrees from the University of Maryland and completed her training in the Pharmaceutical Outcomes Research and Policy Program at the University of Washington. She serves on editorial advisory boards for Value in Health and Health Services Research. She is currently serving as Immediate Past-President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).